(R)-Irsenontrine
Modify Date: 2025-09-02 16:09:28
(R)-Irsenontrine structure
|
Common Name | (R)-Irsenontrine | ||
|---|---|---|---|---|
| CAS Number | 1429509-81-8 | Molecular Weight | 390.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H22N4O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (R)-Irsenontrine(R)-Irsenontrine ((R)-E2027), the R-enantiomer of Irsenontrine (HY-132821), is a potent phosphodiesterase 9 (PDE9) inhibitor with an IC50 value of 0.041 μM. (R)-Irsenontrine can be used for the research of neurological diseases[1]. |
| Name | (R)-Irsenontrine |
|---|
| Description | (R)-Irsenontrine ((R)-E2027), the R-enantiomer of Irsenontrine (HY-132821), is a potent phosphodiesterase 9 (PDE9) inhibitor with an IC50 value of 0.041 μM. (R)-Irsenontrine can be used for the research of neurological diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
PDE9:0.041 μM (IC50) |
| References |
[1]. Yoshihiko N, et, al. Pyrazoloquinoline derivative. WO2013051639A1. |
| Molecular Formula | C22H22N4O3 |
|---|---|
| Molecular Weight | 390.44 |
| InChIKey | CKJDCNZBABIEBZ-OAHLLOKOSA-N |
| SMILES | COc1ncc(C)c(-c2ccc3c(c2)[nH]c(=O)c2cnn(C4CCOC4)c23)c1C |